| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A model for oversight of rare disease studies: The 25-year experience of the cystic fibrosis foundation data safety monitoring board
|
Quittell, Lynne M.
|
|
|
23 |
4 |
p. 734-738
|
artikel
|
| 2 |
Case report of two adults with F508del/3849+10 kb C > T genotype regaining exocrine pancreatic function following treatment with elexacaftor/tezacaftor/ivacaftor
|
Stastna, Nela
|
|
|
23 |
4 |
p. 744-745
|
artikel
|
| 3 |
Centralized intestinal organoid generation is a feasible and safe approach for personalized medicine as demonstrated in the HIT-CF Europe Organoid Study
|
Bierlaagh, Marlou C.
|
|
|
23 |
4 |
p. 703-706
|
artikel
|
| 4 |
Clinical efficacy of CFTR modulator therapy in people with cystic fibrosis carrying the I1234V mutation
|
Aluma, Bat El Bar
|
|
|
23 |
4 |
p. 685-689
|
artikel
|
| 5 |
Covid-19 in cystic fibrosis patients compared to the general population: Severity and virus-host cell interactions
|
Ciciriello, Fabiana
|
|
|
23 |
4 |
p. 625-632
|
artikel
|
| 6 |
Cystic fibrosis cell models for high-throughput analysis and drug screening
|
Liu, Aidi
|
|
|
23 |
4 |
p. 716-724
|
artikel
|
| 7 |
Cystic fibrosis newborn screening in Switzerland – evaluation and scenarios for improvement after 11 years of follow-up
|
Pedersen, ESL
|
|
|
23 |
4 |
p. 796-803
|
artikel
|
| 8 |
Early onset of abnormal glucose tolerance in patients with cystic fibrosis: A systematic review and meta-analysis
|
Kéri, Adrienn F.
|
|
|
23 |
4 |
p. 616-624
|
artikel
|
| 9 |
ECFS standards of care on CFTR-related disorders: Identification and care of the disorders
|
Simmonds, N.J.
|
|
|
23 |
4 |
p. 590-602
|
artikel
|
| 10 |
Every CFTR variant counts – Target-capture based next-generation-sequencing for molecular diagnosis in the German CF Registry
|
Ahting, Simone
|
|
|
23 |
4 |
p. 774-781
|
artikel
|
| 11 |
First report of whole CFTR gene duplication in a healthy newborn carrying R74W and V855I variants on the same allele
|
Diana, Anna
|
|
|
23 |
4 |
p. 690-692
|
artikel
|
| 12 |
Guiding caregivers of infants with CF in understanding differences in pediatric growth charts
|
Bass, Rosara
|
|
|
23 |
4 |
p. 771-773
|
artikel
|
| 13 |
Heterogeneity of CFTR modulator-induced sweat chloride concentrations in people with cystic fibrosis
|
Zemanick, E.T.
|
|
|
23 |
4 |
p. 676-684
|
artikel
|
| 14 |
Impact of lumacaftor/ivacaftor on nutrition and growth in modulator-naïve children over 24 weeks
|
Tindall, Alyssa
|
|
|
23 |
4 |
p. 758-763
|
artikel
|
| 15 |
Implementation and evaluation of a fertility preservation telehealth counseling intervention for males with cystic fibrosis
|
Woods, Brittany M.
|
|
|
23 |
4 |
p. 658-663
|
artikel
|
| 16 |
Improved early growth in Danish children with cystic fibrosis from 2000-2022
|
Bader-Larsen, Karlen
|
|
|
23 |
4 |
p. 764-770
|
artikel
|
| 17 |
Incorporating the perspectives of participants and research coordinators on home spirometry into clinical trial design: The example of the OUTREACH study
|
M, Rosenfeld
|
|
|
23 |
4 |
p. 739-743
|
artikel
|
| 18 |
In vitro modulator responsiveness of 655 CFTR variants found in people with cystic fibrosis
|
Bihler, Hermann
|
|
|
23 |
4 |
p. 664-675
|
artikel
|
| 19 |
Molecular diagnosis of cystic fibrosis by RNA obtained from nasal epithelial cells
|
Prior-de Castro, Carmen
|
|
|
23 |
4 |
p. 788-795
|
artikel
|
| 20 |
News article
|
|
|
|
23 |
4 |
p. 587-589
|
artikel
|
| 21 |
Optimizing sexual reproductive health of men and women with cystic fibrosis: A systematic review
|
Iyer, Anand G.
|
|
|
23 |
4 |
p. 633-638
|
artikel
|
| 22 |
Palliative care needs among outpatient adults with cystic fibrosis: Baseline data from the Improving Life with CF trial
|
DiFiglia, Stephanie
|
|
|
23 |
4 |
p. 804-810
|
artikel
|
| 23 |
Pancreatic enzyme prescription following ivacaftor licensing: A retrospective analysis of the US and UK cystic fibrosis registries
|
Calthorpe, Rebecca
|
|
|
23 |
4 |
p. 746-753
|
artikel
|
| 24 |
Pharmacologic contraception methods for people with cystic fibrosis: A practical review for clinicians
|
Elson, E. Claire
|
|
|
23 |
4 |
p. 653-657
|
artikel
|
| 25 |
Prioritizing sexual and reproductive health research and care for people with cystic fibrosis: A 2023 workshop report from the Cystic Fibrosis Foundation Sexual Health, Reproduction, and Gender (SHARING) Research Working Group
|
Kazmerski, Traci M
|
|
|
23 |
4 |
p. 639-646
|
artikel
|
| 26 |
Remote endpoints for clinical trials in cystic fibrosis: Report from the U.S. CF foundation remote endpoints task force
|
Hoppe, Jordana E.
|
|
|
23 |
4 |
p. 725-733
|
artikel
|
| 27 |
Repeatability and reproducibility of the Forskolin-induced swelling (FIS) assay on intestinal organoids from people with Cystic Fibrosis
|
Bierlaagh, Marlou C.
|
|
|
23 |
4 |
p. 693-702
|
artikel
|
| 28 |
Sexual dysfunction in cystic fibrosis
|
Ramel, Sophie
|
|
|
23 |
4 |
p. 647-652
|
artikel
|
| 29 |
Should all children with cystic fibrosis who have responsive CFTR mutations be prescribed CFTR modulators?
|
Massie, John
|
|
|
23 |
4 |
p. 612-615
|
artikel
|
| 30 |
The clinical utility of sequencing the entirety of CFTR
|
Sheridan, Molly B
|
|
|
23 |
4 |
p. 707-715
|
artikel
|
| 31 |
The importance of understanding cost burden in CF
|
Dieni, Olivia
|
|
|
23 |
4 |
p. 811
|
artikel
|
| 32 |
The new face of cystic fibrosis in the era of population genetic carrier screening
|
Dotan, Miri
|
|
|
23 |
4 |
p. 782-787
|
artikel
|
| 33 |
Update on the diagnosis and management of cystic fibrosis pulmonary exacerbations
|
Cogen, Jonathan D.
|
|
|
23 |
4 |
p. 603-611
|
artikel
|
| 34 |
Vitamin D status and variable responses to supplements depend in part on genetic factors in adults with cystic fibrosis
|
Braun, Andrew T.
|
|
|
23 |
4 |
p. 754-757
|
artikel
|
Tijdschrift beschrijving